HealthStream, Inc.: financial analysis
Ratios worked out from 10 fiscal years of HealthStream, Inc.'s statements, compared with 30 companies in Healthcare Information Services.
HealthStream, Inc. scorecard#
Passes 15 of the 25 checks that could be worked out: strongest in shareholder returns (5 of 5), weakest in valuation (1 of 6). Fiscal year 2025; market cap of Oct 14, 2026.
Valuation1 of 6
- ✗P/E below its peers' median50.5×P/E 50.5× against Healthcare's median of 30.0×.
- ✗Price to book below its peers' median2.9×Price to book 2.9× against Healthcare Information Services's median of 1.9×.
- ✗Price to sales below its peers' median3.1×Price to sales 3.1× against Healthcare Information Services's median of 1.7×.
- ✓Free cash flow yield above 5%5.8%Free cash flow is 5.8% of the market value.
- ✗Earnings yield above the 10-year Treasury yield2.0%Earnings yield 2.0% against the 10-year Treasury's 5.15% on 2026-11-13.
- ✗The price assumes slower growth than the last three years'6.2%The price assumes 6.2% a year for ten years; revenue grew 4.5% a year over the last three.
Growth3 of 6
- ✓Revenue grew in the newest year4.3%Revenue up 4.3% in fiscal 2025.
- ✗Revenue up more than 5% a year over three years4.5%4.5% a year over the three years to fiscal 2025.
- ✗Faster growth over three years than its peers' median4.5%4.5% a year against Healthcare Information Services's median of 6.1% (27 companies).
- ✗Earnings per share grew in the newest year0.61 vs 0.66Diluted EPS 0.61 in fiscal 2025 against 0.66 the year before (report's currency).
- ✓Net income higher than five years earlier$18 M$18 M in fiscal 2025 against $14 M in 2020.
- ✓Revenue rose in at least four of the last five years5 of 5Revenue rose in 5 of the five years to fiscal 2025.
Profitability4 of 5
- ✓Profitable in the newest year$18 MNet income $18 M in fiscal 2025.
- ✓Profitable in each of the last five years5 of 5Profitable in 5 of the five years to fiscal 2025.
- ✓Operating margin above its peers' median6.7%6.7% against Healthcare Information Services's median of -7.1% (29 companies).
- ✗Return on equity above 15%5.1%5.1% in fiscal 2025.
- –Return on invested capital above 10%No return on invested capital on file.
- ✓Operating margin wider than three years earlier6.7%6.7% in fiscal 2025 against 4.7% in 2022.
Financial health2 of 3
- ✗Short-term assets cover short-term liabilities1.0×Current ratio 0.96 at the end of fiscal 2025.
- –Debt below equityDebt or equity is not on file (or equity is negative).
- –Net debt below three years of EBITDANet debt to EBITDA is not on file.
- –Operating income covers interest five timesInterest expense is not on file.
- ✓Cash from operations positive in each of the last three years3 of 3Positive in 3 of the three years to fiscal 2025.
- ✓Altman Z-score outside the distress zone4.76Z-score 4.76 (safe zone) for fiscal 2025.
Shareholder returns5 of 5
- ✓Pays a dividendYesPaid dividends in fiscal 2025.
- –Dividend per share raised five years in a rowSix years of dividends per share are not on file.
- ✓Dividends under 75% of net income20.2%Dividends were 20.2% of net income in fiscal 2025.
- ✓Share count up no more than 2% in a year-1.3%Diluted shares down 1.3% in fiscal 2025.
- ✓Dividends and buybacks above 3% of the market value3.3%Dividends and buybacks were 3.3% of the market value.
- ✓Free cash flow covers dividends and buybacks$60 MFree cash flow $60 M against $34 M paid out in fiscal 2025.
Worked out from the statements as filed (sec), the medians of Healthcare Information Services, the 10-year Treasury yield of Nov 13, 2026 and the market cap. A check that cannot be worked out counts neither way. A reading aid, not advice. How the checks work
What the 2025 statements show#
Each line is an observation with its numbers, not a judgement of the company.
Strengths
- Revenue has grown 5 years in a row.
- Free cash flow has been positive 17 years in a row.
Worth a look
- Liabilities due within a year exceed current assets (current ratio 0.96).
Piotroski F-score
Nine yes/no tests of whether the company's finances improved in the year. One point each.
- Made a profityes
- Operations brought in cashyes
- Return on assets roseno
- Cash from operations exceeds profityes
- Long-term debt fell against assetsnot on file
- Current ratio roseno
- No new shares issuedyes
- Gross margin rosenot on file
- Asset turnover roseyes
Altman Z-score
A 1968 formula that weighs five balance-sheet ratios. It was built on listed manufacturers and says less about other kinds of company.
| Part | Ratio | Weight | Points |
|---|---|---|---|
| Working capital to assets | -0.01 | × 1.2 | -0.01 |
| Retained earnings to assets | 0.24 | × 1.4 | 0.33 |
| Operating income to assets | 0.04 | × 3.3 | 0.13 |
| Market value to liabilities | 6.21 | × 0.6 | 3.73 |
| Revenue to assets | 0.58 | × 1 | 0.58 |
Where the return on equity comes from
The DuPont split: margin, times how hard the assets work, times how much of them is financed by others.
Profitability#
| Fiscal year | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | Median of peers | Ahead of |
|---|---|---|---|---|---|---|---|---|
| Operating margin | 6.7% | 7.3% | 5.7% | 4.7% | 3.1% | -7.1% | 75% | |
| Net margin | 6.0% | 6.9% | 5.5% | 4.5% | 2.3% | -6.8% | 82% | |
| Return on equity | 5.1% | 5.7% | 4.5% | 3.6% | 1.7% | -0.8% | 73% | |
| Return on assets | 3.6% | 4.0% | 3.1% | 2.5% | 1.2% | -2.6% | 76% |
Growth#
| Fiscal year | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | Median of peers | Ahead of |
|---|---|---|---|---|---|---|---|---|
| Revenue growth | 4.3% | 4.5% | 4.6% | 3.9% | 4.9% | 8.7% | 36% | |
| Revenue growth, 3 years a year | 4.5% | 4.4% | 4.5% | 1.6% | 3.5% | 6.1% | 42% | |
| Revenue growth, 5 years a year | 4.4% | 2.8% | 3.8% | 4.4% | 6.0% | 12.4% | 27% | |
| Net income growth | -8.4% | 31.6% | 25.8% | 107.0% | -58.6% | 27.3% | 20% | |
| Earnings per share growth | -7.6% | 32.0% | 28.2% | 116.7% | -59.1% | 17.2% | 22% |
Financial strength#
| Fiscal year | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | Median of peers | Ahead of |
|---|---|---|---|---|---|---|---|---|
| Current ratio | 0.96× | 1.32× | 1.10× | 0.98× | 1.06× | 2.61× | 15% | |
| Equity share of assets | 68.0% | 70.4% | 68.2% | 67.1% | 69.7% | 62.3% | 61% |
Cash#
| Fiscal year | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | Median of peers | Ahead of |
|---|---|---|---|---|---|---|---|---|
| Free cash flow | $60 M | $56 M | $62 M | $49 M | $39 M | $24 M | 60% | |
| Free cash flow margin | 19.6% | 19.3% | 22.1% | 18.5% | 15.2% | 14.1% | 65% | |
| Cash conversion | 345.3% | 288.2% | 420.6% | 423.4% | 725.7% | 304.9% | 55% | |
| Capital spending share of revenue | 1.2% | 0.5% | 0.8% | 0.7% | 1.3% | 0.7% | — |
Efficiency#
| Fiscal year | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | Median of peers | Ahead of |
|---|---|---|---|---|---|---|---|---|
| Asset turnover | 0.59× | 0.58× | 0.56× | 0.54× | 0.52× | 0.59× | 50% |
How each figure is worked out#
- Operating margin
- Operating income as a share of revenue.
- Net margin
- Net income as a share of revenue.
- Return on equity
- Net income as a share of shareholders' equity (the average of the start and the end of the year). Not given when equity is negative.
- Return on assets
- Net income as a share of total assets (average of the year).
- Revenue growth
- Revenue against the year before.
- Revenue growth, 3 years a year
- The yearly rate that takes revenue of three years earlier to this year's.
- Revenue growth, 5 years a year
- The yearly rate that takes revenue of five years earlier to this year's.
- Net income growth
- Net income against the year before. Only when both years were profitable.
- Earnings per share growth
- Diluted earnings per share against the year before. Only when both were positive.
- Current ratio
- Assets due within a year divided by liabilities due within a year.
- Equity share of assets
- Shareholders' equity as a share of total assets.
- Free cash flow
- Cash from operations less capital spending.
- Free cash flow margin
- Free cash flow as a share of revenue.
- Cash conversion
- Cash from operations as a share of net income. Only when the year was profitable.
- Capital spending share of revenue
- Capital spending as a share of revenue.
- Dividend yield
- Dividends paid in the fiscal year as a share of today's market value.
- Buyback yield
- Shares bought back in the fiscal year as a share of today's market value.
- Shareholder yield
- Dividends plus buybacks as a share of today's market value.
- Dividend payout
- Dividends paid as a share of net income. Only when the year was profitable.
- Change in share count
- Diluted shares against the year before. Negative: fewer shares.
- Asset turnover
- Revenue divided by total assets (average of the year).
Source: HealthStream, Inc.'s statements: annual reports filed with the SEC. Arithmetic on reported figures, in US dollars; nothing is estimated. A figure is blank when a line it needs is not in the statements on file, and left out when the result cannot be right (a margin from next to no revenue). "Ahead of" is the share of the 30 companies in Healthcare Information Services that HealthStream, Inc. is better than on that figure, using each company's newest fiscal year; yields use today's market value. Medians for every industry · Back to HealthStream, Inc.